Fri, Apr 07, 2023 | By Cryoport Team
Cryoport Systems has extended its expertise in temperature-controlled supply chain solutions with vein-to-vein BioServices offerings. BioServices expands our supply chain solutions in order to better...
Tue, Feb 28, 2023 | By Cryoport Team
Cryoport Systems has grown to become a leader in the cell and gene therapy industry since its founding in 1999. Throughout those 20+ years, we've seen how both the growth and transformation of the...
Wed, Nov 30, 2022 | By Cryoport Team
Cryoport combines its expertise in temperature-controlled supply chain solutions to develop a comprehensive offering of vein-to-vein services, one of which includes Kit Production. From clinical to...
Mon, Aug 22, 2022 | By Rob Jones, Vice President of Global BioServices
Cryoport Systems’ highly anticipated Global Supply Chain Centers have been operational for a few months, and customers continue to move biopharmaceutical materials into our Houston, Texas and Morris...
Americas • EMEA • APAC
Sales • +1 949.470.2300 | Support • +1 949.470.2305
©2023 Cryoport Systems, LLC. All rights reserved.
A Leap Forward in Standardizing the Regenerative Medicine Supply Chain – What the New ISO 21973 Guidance Means for Cell and Gene Therapy Developers
Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC
